HELEN REIDLER: Open Payments
NPI 1639506553 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 89 payments from 22 companies in 2025. Trend: 2023 $1,655 · 2024 $1,317 · 2025 $1,840
Food & beverage: $1,840
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 24 | $325 |
| Medtronic, Inc. | 7 | $202 |
| Janssen Biotech, Inc. | 5 | $198 |
| UROGEN PHARMA, INC. | 11 | $177 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $120 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Endo USA, Inc. | 4 | $97 |
| TOLMAR, INC. | 3 | $75 |
| Antares Pharma, Inc. | 4 | $74 |
| PFIZER INC. | 4 | $73 |
Products named: ERLEADA, INTERSTIM, JELMYTO, GEMTESA, ORGOVYX, Nubeqa, PLUVICTO, Xtandi.
Industry payments across MD — which companies pay providers there.
